Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 13 04:00PM ET
9.75
Dollar change
+0.23
Percentage change
2.42
%
IndexRUT P/E- EPS (ttm)-5.69 Insider Own45.07% Shs Outstand57.97M Perf Week-45.83%
Market Cap666.68M Forward P/E- EPS next Y-4.10 Insider Trans-0.16% Shs Float37.56M Perf Month-37.74%
Income-339.44M PEG- EPS next Q-1.20 Inst Own56.83% Short Float46.46% Perf Quarter-25.60%
Sales26.27M P/S25.38 EPS this Y-38.36% Inst Trans12.30% Short Ratio14.31 Perf Half Y-6.34%
Book/sh-2.74 P/B- EPS next Y24.54% ROA-108.79% Short Interest17.45M Perf Year36.36%
Cash/sh4.89 P/C1.99 EPS next 5Y- ROE- 52W Range6.07 - 19.71 Perf YTD6.79%
Dividend Est.- P/FCF- EPS past 5Y-137.06% ROI-109.14% 52W High-50.53% Beta0.60
Dividend TTM- Quick Ratio5.68 Sales past 5Y0.00% Gross Margin82.83% 52W Low60.76% ATR (14)1.68
Dividend Ex-Date- Current Ratio5.73 EPS Y/Y TTM-48.61% Oper. Margin-1096.02% RSI (14)25.62 Volatility24.18% 10.90%
Employees452 Debt/Eq- Sales Y/Y TTM- Profit Margin-1292.14% Recom1.29 Target Price25.29
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-73.87% Payout- Rel Volume2.79 Prev Close9.52
Sales Surprise29.69% EPS Surprise10.12% Sales Q/Q- EarningsNov 07 BMO Avg Volume1.22M Price9.75
SMA20-39.73% SMA50-42.43% SMA200-19.56% Trades Volume3,402,401 Change2.42%
Date Action Analyst Rating Change Price Target Change
May-03-24Initiated Stifel Buy $24
Jan-05-24Reiterated Needham Buy $23 → $26
Aug-09-23Initiated H.C. Wainwright Buy $28
May-11-23Upgrade Evercore ISI In-line → Outperform
Mar-13-23Initiated Craig Hallum Buy $21
Oct-21-22Initiated Jefferies Buy $16
May-06-22Downgrade Evercore ISI Outperform → In-line
May-12-21Upgrade Goldman Sell → Neutral $40 → $48
Feb-17-21Initiated BMO Capital Markets Outperform $63
Feb-02-21Initiated Guggenheim Buy $60
Nov-08-24 06:02AM
Nov-07-24 09:20AM
08:00AM
Nov-06-24 07:21AM
Nov-04-24 08:00AM
08:00AM Loading…
Oct-28-24 08:00AM
Oct-27-24 12:00PM
Aug-29-24 08:00AM
Aug-19-24 08:00AM
Aug-08-24 09:20AM
08:00AM
Jul-30-24 08:00AM
Jul-29-24 07:59AM
Jul-18-24 08:00AM
Jun-09-24 07:00AM
06:17AM Loading…
Jun-07-24 06:17AM
May-28-24 08:00AM
May-15-24 08:00AM
May-13-24 11:02AM
May-10-24 08:00AM
May-09-24 09:15AM
08:00AM
May-03-24 08:02AM
Apr-29-24 08:00AM
Apr-22-24 03:30AM
Apr-19-24 03:03PM
11:02AM
Apr-05-24 06:30PM
Apr-03-24 08:00AM
Mar-26-24 08:00AM
03:05PM Loading…
Mar-08-24 03:05PM
01:57AM
Mar-07-24 01:51PM
01:38PM
08:00AM
Feb-29-24 08:00AM
Feb-13-24 08:00AM
Jan-31-24 08:00AM
Dec-14-23 08:00AM
Dec-06-23 08:00AM
Nov-28-23 08:00AM
Nov-09-23 09:34AM
08:00AM
Nov-01-23 05:00PM
Oct-30-23 08:00AM
Oct-25-23 08:01AM
Sep-26-23 08:01AM
Sep-05-23 08:00AM
Aug-21-23 08:00AM
Aug-10-23 08:01AM
Aug-09-23 10:26AM
Aug-07-23 02:34PM
Jul-14-23 04:40PM
Jul-10-23 08:26AM
Jul-07-23 08:38AM
06:52AM
Jun-12-23 08:01AM
Jun-09-23 04:01PM
Jun-01-23 09:55AM
08:00AM
May-27-23 09:07AM
May-26-23 09:55AM
May-25-23 09:55AM
May-23-23 07:41PM
04:01PM
04:00PM
May-10-23 08:00AM
May-09-23 08:00AM
Apr-12-23 08:00AM
07:07AM
Apr-10-23 06:44AM
Apr-05-23 08:35AM
Apr-04-23 08:00AM
Mar-27-23 09:55AM
Mar-07-23 12:00PM
Feb-28-23 08:00AM
Feb-10-23 08:53AM
07:59AM
Feb-09-23 04:01PM
Jan-28-23 01:58PM
Jan-24-23 09:02AM
Jan-13-23 06:56AM
Jan-08-23 06:00PM
Jan-06-23 05:02AM
Jan-05-23 11:31AM
Jan-04-23 09:17AM
Jan-03-23 04:01PM
Nov-08-22 05:00PM
Nov-03-22 08:30AM
Nov-01-22 08:00AM
Oct-24-22 08:00AM
Oct-23-22 12:01PM
Oct-18-22 08:00AM
Sep-26-22 08:00AM
Sep-07-22 08:15AM
Aug-17-22 09:16AM
Aug-02-22 08:00AM
Jun-01-22 08:15AM
May-25-22 08:00AM
May-24-22 12:15PM
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nabulsi AzmiChief Operating OfficerJul 15 '24Sale11.7210,901127,760240,421Jul 17 02:52 PM
Henderson MollyCFO and CBOJul 15 '24Sale11.724,32550,68999,447Jul 17 02:51 PM
Curran TerriePresident and Chief ExecutiveJul 15 '24Sale11.7233,848396,699377,734Jul 17 02:50 PM
Henderson MollyCFO and CBOApr 08 '24Sale11.103,43538,12895,263Apr 10 04:30 PM
Curran TerriePresident and Chief ExecutiveMar 22 '24Sale9.1116,851153,513410,784Mar 26 04:05 PM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJan 24 '24Sale8.103,703,70329,999,9943,755,583Jan 25 06:13 AM
Henderson MollyCFO and CBOJan 19 '24Sale7.756,30748,90098,698Jan 22 08:22 PM
Henderson MollyCFO and CBONov 20 '23Sale7.242,12715,403103,061Nov 21 04:40 PM